Praedicare Inc. is an end-to-end drug development company [from drug discovery to phase IV trials] that uses preclinical wet lab models mathematically mapped to patients for quantitative prediction of clinical trial outcomes, significantly reducing clients’ risk, time, and costs of developing safe and effective new drugs. Praedicare is headquartered in Dallas, Texas, but has international offices and has clients from around the globe.